Both Apollo and Sanofi would endeavour to expand Apollo Sugar to provide superior value to patients and doctors with an enhanced geographic reach
Apollo Health and Lifestyle Limited (AHLL), a wholly owned subsidiary of Apollo Hospitals Enterprise, announced that Sanofi-Synthelabo (India) has invested into Apollo Sugar Clinics Limited (ASCL).
Apollo Sugar, reportedly offers access to an integrated diabetes care solution via a combination of high quality clinical infrastructure including early detection and protocol driven treatment of diabetes, complemented by a robust set of lifestyle management programmes. Through this investment, both Apollo and Sanofi would endeavour to expand Apollo Sugar to provide superior value to patients and doctors with an enhanced geographic reach, and provide high quality outcome oriented set of services
Commenting on the collaboration, Dr Prathap Reddy, Chairman and Founder, Apollo Hospitals Group shared “Over the years, Apollo Hospitals has benchmarked global best practices in quality healthcare delivery with stringent alignment to approved standards and protocols. With the increasing burden of diabetes in our society, we need to act quickly and with a sense of purpose to arrest the disease from claiming more lives. I am confident that with this investment, Apollo Sugar Clinics is even better positioned to offer patients advanced care and counselling for diabetes management. This is a good start towards improving the diabetes management programme in India and I am delighted to be partnering with Sanofi, a global leader in diabetes management. Our shared vision will provide a new approach to diabetes care to benefit patients in India and other parts of the world.”
While the population of people with diabetes in India is very high, many patients are either unaware of their condition, or are poorly controlled. They need better awareness about the disease, its complications, management and access to the latest treatment options. Sangita Reddy, Chairperson, Apollo Sugar and Joint MD, Apollo Hospitals said, “We have presented at the American Diabetes Association conference and have been recognised for delivering exceptional clinical outcomes in managing diabetes, some of which were attempted and successful for the first time in India. However, we as a country are still battling with the image of being the diabetes capital of the world. We understand that a diagnosis of diabetes and pursuit of necessary lifestyle changes is daunting for patients. At Apollo Sugar, a patient with diabetes has access to information, the right treatment, co-morbidities management, counselling, care and treatment to sustainably manage diabetes. We are now keen to take Apollo Sugar’s comprehensive offering to many more parts of India.”
Commenting on the investment by Sanofi, Neeraj Garg, CEO of Apollo Health & Lifestyle said, “At Apollo Sugar, we offer best in class clinical care delivered in our conveniently located facilities, and combine it with a comprehensive, 360° patient lifestyle management program to help patients to successfully manage diabetes and avoid related complications. The investments made by Sanofi, and the strong support of both our shareholders, enables us to grow our footprint to offer our services at many more clinics across India, and provide millions of diabetic customers’ access to world class care at their doorstep.